preclinical safety evaluation found no genotoxicity, mutagenicity, or organ toxicity at tested doses
Injections can be administered once a week
Pierre Maechler, Universit de Genve) and all clonally-derived cell lines were cultured as described previously 7,10,42
The published research literature has investigated: Angiogenic effects (formation of new blood vessels in damaged tissue) VEGFR2 receptor activity modulation Growth factor expression Tissue protection in gastrointestinal, vascular, and musculoskeletal contexts Wound healing in multiple tissue models GHK-Cu mechanisms
More diluent buys precision exactly where you need it, at the bottom of the ladder
Serious adverse events have not been widely reported, but this may reflect the relatively small number of people who have used the compound and the limited reporting mechanisms available